Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

telemedicine
News
Dupilumab Demonstrates Efficacy Across All Levels of Prurigo Nodularis Severity: Combined Results from Phase 3 Trials
06/23/2024
Riya Gandhi, MA, Associate Editor
In a comprehensive analysis pooling data from 2 pivotal phase 3 trials, researchers have shown that dupilumab effectively alleviates pruritus and reduces skin lesions in patients with prurigo nodularis, irrespective of the severity of their...
In a comprehensive analysis pooling data from 2 pivotal phase 3 trials, researchers have shown that dupilumab effectively alleviates pruritus and reduces skin lesions in patients with prurigo nodularis, irrespective of the severity of their...
In a comprehensive analysis...
06/23/2024
The Dermatologist
eczema
News
Novel Efficacy Index Compares Long-Term Therapy Outcomes in Atopic Dermatitis Treatments
06/22/2024
Riya Gandhi, MA, Associate Editor
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
In a new approach to assess...
06/22/2024
The Dermatologist

Advertisement

Atopic dermatitis
News
Improving Biomarkers in Atopic Dermatitis: Insights from Lebrikizumab Studies
06/21/2024
Riya Gandhi, MA, Associate Editor
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
In recent findings from the...
06/21/2024
The Dermatologist
psoriasis
News
Systemic Immunity-Inflammation Index Associated With Psoriasis
06/20/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the...
06/20/2024
The Dermatologist
psoriatic arthritis
News
Readmissions After Hospitalization for Psoriatic Arthritis
06/20/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to assess the rates, characteristics, and predictors of 30-day readmissions among adults hospitalized for psoriatic arthritis across the United States.
Researchers aimed to assess the rates, characteristics, and predictors of 30-day readmissions among adults hospitalized for psoriatic arthritis across the United States.
Researchers aimed to assess the...
06/20/2024
The Dermatologist

Advertisement

Atopic dermatitis
News
Lebrikizumab for Moderate to Severe Atopic Dermatitis in Patients Age ≥60 Years
06/20/2024
Jessica Garlewicz, Digital Managing Editor
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD)...
06/20/2024
The Dermatologist
AD
News
Ruxolitinib Cream for Patients With Facial and/or Neck Atopic Dermatitis
06/19/2024
Jessica Garlewicz, Digital Managing Editor
In a presentation showcased at the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, a study evaluated the efficacy and safety of 1.5% ruxolitinib cream in treating AD in face/neck.
In a presentation showcased at the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, a study evaluated the efficacy and safety of 1.5% ruxolitinib cream in treating AD in face/neck.
In a presentation showcased at...
06/19/2024
The Dermatologist
vitiligo
News
Vitiligo Biomarker CXCL10 Correlation With Clinical Response
06/18/2024
Jessica Garlewicz, Digital Managing Editor
During the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, presenters showcased how ruxolitinib cream, a topical Janus kinase 1/JAK2 inhibitor, is the first US Food and Drug Administration and European Commission-approved...
During the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, presenters showcased how ruxolitinib cream, a topical Janus kinase 1/JAK2 inhibitor, is the first US Food and Drug Administration and European Commission-approved...
During the Revolutionizing...
06/18/2024
The Dermatologist

Advertisement

SOC
News
Shifting the Care Paradigm for Individuals With Skin of Color
06/17/2024
Jessica Garlewicz, Digital Managing Editor
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology...
06/17/2024
The Dermatologist
social media
News
Real-world Insights: Physician-assessed and Patient-reported Outcomes in Atopic Dermatitis Patients Treated with Dupilumab
06/16/2024
Riya Gandhi, MA, Associate Editor
A recent update from the GLOBOSTAD study offered valuable insights into the real-world effectiveness of dupilumab, a promising treatment for atopic dermatitis.
A recent update from the GLOBOSTAD study offered valuable insights into the real-world effectiveness of dupilumab, a promising treatment for atopic dermatitis.
A recent update from the...
06/16/2024
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

August 2024
Volume 32
Issue 5
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

NEA Approved Features
Addressing Itch
08/19/2020
Jill Waldbieser, Managing Editor
Itch is one of the most common—and distressing—symptoms of atopic dermatitis, and effectively treating it requires an understanding of the underlying pathology of the disease.
Itch is one of the most common—and distressing—symptoms of atopic dermatitis, and effectively treating it requires an understanding of the underlying pathology of the disease.
Itch is one of the most...
08/19/2020
The Dermatologist
Derm Dx
What are These Shiny Pink Papules?
12/10/2012
A 92-year-old white male presented to the dermatology clinic with two pink shiny growths on his retroauricular scalp that had been growing slowly for several months.
A 92-year-old white male presented to the dermatology clinic with two pink shiny growths on his retroauricular scalp that had been growing slowly for several months.
A 92-year-old white male...
12/10/2012
The Dermatologist
Podcasts
Dr Green Shares His Tips for Managing Psoriasis in Teens
12/10/2019
Dr Lawrence Green, with George Washington University School of Medicine, discusses his treatment strategies for managing psoriasis in teenagers.
Dr Lawrence Green, with George Washington University School of Medicine, discusses his treatment strategies for managing psoriasis in teenagers.
Dr Lawrence Green, with George...
12/10/2019
The Dermatologist
Spotlight
Spotlight On: Philip R. Cohen, MD
08/08/2012
In dermatology, we are fortunate to have many insightful practitioners and great teachers and mentors. Some are bright stars in our special universe – others unsung heroes. All of these colleagues have much to share from wisdom to humor to...
In dermatology, we are fortunate to have many insightful practitioners and great teachers and mentors. Some are bright stars in our special universe – others unsung heroes. All of these colleagues have much to share from wisdom to humor to...
In dermatology, we are fortunate...
08/08/2012
The Dermatologist
Videos
Improving Program Transparency in Dermatology
10/19/2020
A recent study found both applicants to dermatology residency programs and program directors believe there needs to be more transparency between residency programs and applicants. Study authors, Kristin Nord, MD, and Justin Jia discuss...
A recent study found both applicants to dermatology residency programs and program directors believe there needs to be more transparency between residency programs and applicants. Study authors, Kristin Nord, MD, and Justin Jia discuss...
A recent study found both...
10/19/2020
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
Riya Gandhi, MA, Associate Editor
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Riya Gandhi, MA, Associate Editor
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Kids + Legs + Elbow + Knee
Quiz
Quiz: Navigating New Therapies in Atopic Dermatitis
04/10/2024
Riya Gandhi, MA, Associate Editor
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr...
04/10/2024
The Dermatologist
AD
Quiz
Trivia: Atopic Dermatitis Patients With Alopecia Areata
02/28/2024
Riya Gandhi, MA, Associate Editor
02/28/2024
The Dermatologist
AD
Quiz
Trivia: Itch Cycle and OTC Products
12/27/2023
12/27/2023
The Dermatologist
psoriasis
Quiz
Trivia: Recommended Treatment For Psoriasis
12/20/2023
Jessica Garlewicz, Digital Managing Editor
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate...
12/20/2023
The Dermatologist
Ilka Arun Netravali, MD, PhD, FAAD
Quiz
Dupilumab Mechanism of Action
11/07/2023
Jessica Garlewicz, Digital Managing Editor
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview...
11/07/2023
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use